Genetic aspects of osteoporosis
- PMID: 10411385
- DOI: 10.1097/00002281-199907000-00013
Genetic aspects of osteoporosis
Abstract
At a given age, bone mass represents the difference between the maximal amount of bone mineral mass gained during growth (peak bone mass) and post-menopausal and/or senile bone loss. Twins and parents-offspring models have shown a strong inheritance of peak bone mass and it is now known that familial resemblance in various bone mass constituents is detectable well before the pubertal growth spurt. Recent developments in the molecular epidemiology of osteoporosis have focused on the association between areal bone mineral density and common polymorphisms in several candidate genes. Among them, vitamin D receptor (VDR), estrogen receptor and collagen-1 -alpha-1 (COL1A1) genes have been the most extensively investigated. Although controversial results have been reported and osteoporosis cannot be predicted by any single polymorphic gene marker, recent advances in this field have emphasized the complexity of bone mineral mass determination, because of gene-gene and gene-environment interactions.
Similar articles
-
Genetic control of bone density and turnover: role of the collagen 1alpha1, estrogen receptor, and vitamin D receptor genes.J Bone Miner Res. 2001 Apr;16(4):758-64. doi: 10.1359/jbmr.2001.16.4.758. J Bone Miner Res. 2001. PMID: 11316004
-
Heritable and nutritional influences on bone mineral mass.Aging (Milano). 1998 Jun;10(3):205-13. doi: 10.1007/BF03339654. Aging (Milano). 1998. PMID: 9801730 Review.
-
The genetics of osteoporosis.QJM. 1997 Apr;90(4):247-51. doi: 10.1093/qjmed/90.4.247. QJM. 1997. PMID: 9307758 Review.
-
[The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].Ann Acad Med Stetin. 2003;49:111-30. Ann Acad Med Stetin. 2003. PMID: 15552843 Clinical Trial. Polish.
-
Role of genetic factors in the pathogenesis of osteoporosis.J Endocrinol. 2000 Aug;166(2):235-45. doi: 10.1677/joe.0.1660235. J Endocrinol. 2000. PMID: 10927613 Review.
Cited by
-
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.Am J Hum Genet. 2004 May;74(5):866-75. doi: 10.1086/420771. Epub 2004 Apr 7. Am J Hum Genet. 2004. PMID: 15077203 Free PMC article.
-
Genes and osteoporosis.Curr Osteoporos Rep. 2004 Sep;2(3):79-89. doi: 10.1007/s11914-004-0015-1. Curr Osteoporos Rep. 2004. PMID: 16036087 Review.
-
Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.Bone. 2007 Mar;40(3):587-96. doi: 10.1016/j.bone.2006.09.029. Epub 2006 Nov 28. Bone. 2007. PMID: 17137849 Free PMC article.
-
Collagen type I(alpha 1) and vitamin D receptor polymorphisms in diffuse idiopathic skeletal hyperostosis.Clin Rheumatol. 2002 Aug;21(4):347-8. doi: 10.1007/s100670200093. Clin Rheumatol. 2002. PMID: 12296290 No abstract available.
-
An assessment of genetic markers as predictors of bone turnover in healthy adults.J Endocrinol Invest. 2001 Apr;24(4):236-45. doi: 10.1007/BF03343853. J Endocrinol Invest. 2001. PMID: 11383910 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous